Macrocyclic compounds as TRK kinases inhibitors
US11555042B2 · kind B2 · utility
0Cited by
0References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2019 |
| Grant date | Jan 17, 2023 |
| Priority date | — |
| Expiry date | Sep 5, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided are certain TRK inhibitors, pharmaceutical compositions thereof, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.